BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 10608146)

  • 1. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
    Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
    Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
    Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
    Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 9. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays.
    Villalta D; Tozzoli R; Bizzaro N; Tonutti E; Ghirardello A; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1050():176-84. PubMed ID: 16014532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
    Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Ro/SSA and La/SSB antibodies.
    Franceschini F; Cavazzana I
    Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome].
    Zhang FC; Liu L; Xu D
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens.
    Martins TB; Burlingame R; von Mühlen CA; Jaskowski TD; Litwin CM; Hill HR
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1054-9. PubMed ID: 15539505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New coupled-particle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases.
    Bizzaro N; Bonelli F; Tonutti E; Tozzoli R; Villalta D
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):922-5. PubMed ID: 11527804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
    Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
    Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.